Carson Wealth (CWM LLC)’s Arbutus Biopharma ABUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Sell |
2,174
-32
| -1% | -$103 | ﹤0.01% | 4418 |
|
|
2025
Q1 | $8K | Sell |
2,206
-232
| -10% | -$841 | ﹤0.01% | 4188 |
|
|
2024
Q4 | $8K | Sell |
2,438
-62
| -2% | -$203 | ﹤0.01% | 3957 |
|
|
2024
Q3 | $10K | Buy |
2,500
+161
| +7% | +$644 | ﹤0.01% | 3759 |
|
|
2024
Q2 | $7K | Buy |
2,339
+642
| +38% | +$1.92K | ﹤0.01% | 3692 |
|
|
2024
Q1 | $4K | Buy |
1,697
+1,554
| +1,087% | +$3.66K | ﹤0.01% | 3716 |
|
|
2023
Q4 | $0 | Buy |
143
+133
| +1,330% | – | ﹤0.01% | 4085 |
|
|
2023
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 4135 |
|
|
2023
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 4123 |
|
|
2023
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 3991 |
|
|
2022
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 3920 |
|
|
2022
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 3851 |
|
|
2022
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 3719 |
|
|
2022
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 3466 |
|
|
2021
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 3442 |
|
|
2021
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 2875 |
|
|
2021
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 2875 |
|
|
2020
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 2875 |
|
|
2020
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 2875 |
|
|
2020
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 2875 |
|
|
2020
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 2875 |
|
|
2019
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 2875 |
|
|
2019
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 2875 |
|
|
2019
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 2875 |
|
|
2019
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 2877 |
|